Blog

What makes being a project manager so unique in the context of the clinical research enterprise, where you’ll most likely find them working directly for sponsors, or based within contract research organizations, or operating as independent consultants? We scouted around for insights amongst holders of the ACRP Project Manager (ACRP-PM®) specialty certification, and here’s the feedback we received from a few of them about the paths they followed into project management and what they really do in their day-to-day jobs.

Recent findings about impressive dollar figures tied to productivity aside, many questions linger about the practical implications of the use of artificial intelligence (AI) in clinical trial settings, especially at the site level. This blog highlights the perspectives of three authors whose peer-reviewed articles on different aspects of AI integration with clinical research workflows are forthcoming in ACRP's Clinical Researcher journal.

Clinical trial interoperability has evolved beyond a technology integration initiative. It has become an operational priority that influences study execution, data quality, regulatory readiness, and decision-making across the clinical development lifecycle. As organizations seek to modernize their clinical platforms, engineering delivery models are also evolving to support closer alignment between technology implementation and business outcomes. Forward Deployed Engineering is emerging as one such delivery model.

Did you know that the ACRP Board of Trustees includes a public member whose role is to champion the public or consumer interest in the drug and device research and development enterprise? They are chosen to bring new ideas and goals to the table, contribute an unbiased perspective, encourage consumer-oriented positions, and offer additional public accountability and responsiveness. We asked Toni Willis, MD, FAAPMR, the current ACRP Public Member, to share some background on her career and how she came to serve in this volunteer role.

While risk-based quality management has gained increasing acceptance across the clinical research enterprise, quantitative evidence on its financial impact has been limited. A new analysis coauthored by experts from CluePoints and the Tufts Center for the Study of Drug Development addresses this gap.